AVIR · Company research
Atea Pharmaceuticals, Inc. (AVIR): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals (AVIR) Edges Lower to $5.15 as Shares Consolidate Below Resistance - High Low Breadth - dars.gov.et | Atea Pharmaceuticals (AVIR) Edges Lower to $5.15 as Shares Consolidate Below Resistance - High Low Breadth dars.gov.et | View source ↗ | dars.gov.et | Oct 10, 2026 | neutral | 0 | 0.6 |
| Atea Pharmaceuticals (AVIR) Edges Lower to $5.15 as Shares Consolidate Below Resistance - Fear Greed Extreme - https://www.dars.gov.et/ | Atea Pharmaceuticals (AVIR) Edges Lower to $5.15 as Shares Consolidate Below Resistance - Fear Greed Extreme https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 10, 2026 | neutral | 0 | 0.6 |
| A stake in Atea Pharmaceuticals (AVIR) is no longer held to influence control. - Stock Titan | A stake in Atea Pharmaceuticals (AVIR) is no longer held to influence control. Stock Titan | View source ↗ | Stock Titan | Oct 6, 2026 | neutral | 0 | 0.6 |
| AVIR: Atea Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits | AVIR: Atea Pharmaceuticals Inc Latest Stock Price, Analysis, News and Trading Ideas Stocktwits | View source ↗ | Stocktwits | Sep 16, 2026 | neutral | 0 | 0.6 |
| Atea CEO to speak at a New York healthcare conference Sept. 15 - Stock Titan | Atea CEO to speak at a New York healthcare conference Sept. 15 Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| ATEA PHARMACEUTICALS ($AVIR) Releases Q2 2026 Earnings | AVIR Stock News - Quiver Quantitative | ATEA PHARMACEUTICALS ($AVIR) Releases Q2 2026 Earnings | AVIR Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| Atea posts late-stage trial win for hepatitis C drug (AVIR) - Seeking Alpha | Atea posts late-stage trial win for hepatitis C drug (AVIR) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 28, 2026 | neutral | 0 | 0.6 |
| AVIR|Atea Pharmaceuticals Inc|Price:5.065|Chg%:-0.105 - TradingKey | AVIR|Atea Pharmaceuticals Inc|Price:5.065|Chg%:-0.105 TradingKey | View source ↗ | TradingKey | Jul 26, 2026 | neutral | 0 | 0.6 |
| Atea Pharmaceuticals (AVIR) Faces Modest Decline Near Key Support Level - Upthrust Pattern - dars.gov.et | Atea Pharmaceuticals (AVIR) Faces Modest Decline Near Key Support Level - Upthrust Pattern dars.gov.et | View source ↗ | dars.gov.et | Jul 15, 2026 | neutral | 0 | 0.6 |
| AVIR Forecast — Price Target — Prediction for 2027 - TradingView | AVIR Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 26, 2026 | neutral | 0 | 0.6 |
| Atea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should Know - Yahoo Finance | Atea Pharmaceuticals (AVIR) Upgraded to Buy: Here's What You Should Know Yahoo Finance | View source ↗ | Yahoo Finance | Jun 18, 2026 | neutral | 0 | 0.6 |
| Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR) - Seeking Alpha | Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR) Seeking Alpha | View source ↗ | Seeking Alpha | May 29, 2026 | neutral | 0 | 0.6 |
| Down 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a Turnaround - Yahoo Finance | Down 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a Turnaround Yahoo Finance | View source ↗ | Yahoo Finance | May 15, 2026 | neutral | 0 | 0.6 |
| We Think Atea Pharmaceuticals (NASDAQ:AVIR) Needs To Drive Business Growth Carefully - Simply Wall Street | We Think Atea Pharmaceuticals (NASDAQ:AVIR) Needs To Drive Business Growth Carefully Simply Wall Street | View source ↗ | Simply Wall Street | May 14, 2026 | neutral | 0 | 0.6 |
| Atea Pharmaceuticals (AVIR) Stock Forecast and Price Target 2026 $AVIR - MarketBeat | Atea Pharmaceuticals (AVIR) Stock Forecast and Price Target 2026 $AVIR MarketBeat | View source ↗ | MarketBeat | May 11, 2024 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 26, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.